Detecting Immune Response to Therapies Targeting PDL1 and BRAF by Using Ferumoxytol MRI and Macrin in Anaplastic Thyroid Cancer
Author:
Publisher
Radiological Society of North America (RSNA)
Subject
Radiology, Nuclear Medicine and imaging
Link
http://pubs.rsna.org/doi/pdf/10.1148/radiol.2020201791
Reference34 articles.
1. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma
2. An Update of the Appropriate Treatment Strategies in Anaplastic Thyroid Cancer: A Population-Based Study of 735 Patients
3. Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer
4. Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer
5. Combined BRAFV600E- and SRC-inhibition induces apoptosis, evokes an immune response and reduces tumor growth in an immunocompetent orthotopic mouse model of anaplastic thyroid cancer
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Localizedin vivoprodrug activation using radionuclides;2024-08-06
2. Targeted Therapy in Thyroid Cancer;Indian Journal of Endocrine Surgery and Research;2024-06-17
3. Tailoring the surface charges of iron-crosslinked dextran nanogels towards improved tumor-associated macrophage targeting;Carbohydrate Polymers;2024-02
4. New Insights into Immune Cells and Immunotherapy for Thyroid Cancer;Immunological Investigations;2023-10-17
5. Multifunctional polysaccharide nanoprobes for biological imaging;Carbohydrate Polymers;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3